Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Trinity College Develops Gene Therapy for Glaucoma and AMD
A team of researchers at Trinity College Dublin has developed a gene therapy that shows promise for treating both glaucoma and dry age-related macular degeneration (AMD). The therapy, which uses an enhanced gene (eNdi1) delivered by an approved virus, aims…
Visionix Unveils VX 610 Fundus Camera for DR Screening
Visionix USA has introduced the VX 610, a non-mydriatic automated fundus camera designed to improve retinal imaging and diabetic retinopathy screening. The VX 610 features auto alignment, auto focus, and auto capture, allowing for consistent, high-quality imaging with minimal user…
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation – CU Anschutz newsroom
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Ophthalmology Innovator Joins NYU Langone Health as Chief of Oculoplastics – NYU Langone Health
Ophthalmology Innovator Joins NYU Langone Health as Chief of Oculoplastics NYU Langone Health Source: Author: | Date: 2024-09-06 07:00:00 Source: Author: | Date: 2024-09-06 07:00:00
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…
Dangers of Eye Color-Changing Drops: Ophthalmologists Warn
The American Academy of Ophthalmology is warning the public about over-the-counter eye drops that claim to change eye color. These products, popularized on social media platforms like TikTok, are unproven, unregulated, and could pose significant risks to eye health. Unapproved…
Michaël J. A. Girard, PhD – Emory School of Medicine
Michaël J. A. Girard, PhD Emory School of Medicine Source: Author: | Date: 2024-08-23 05:43:00 Source: Author: | Date: 2024-08-23 05:43:00
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…
Sandoz Receives FDA Approval for ENZEEVU™
Sandoz has secured FDA approval for ENZEEVU™ (aflibercept-abzv), a biosimilar to EYLEA®, to treat retinal conditions like wet age-related macular degeneration (AMD) and diabetic retinopathy. This approval strengthens Sandoz’s U.S. biosimilar portfolio, offering a cost-effective alternative for managing retinal diseases.…
AMD Explained: Tips for Safeguarding Your Vision
The eyes are often called the windows to the soul, but what happens when those windows become cloudy and blurred? That’s the reality for millions suffering from age-related macular degeneration (AMD), which can rob you of your precious eyesight as…